Patient-partnered drug discovery: vision or reality?
Paul Tunnah talks to Anthony Yanni, global head, patient centricity, Astellas US, about why partnering with patients is the cornerstone for change throughout the drug development lifecycle
Patient engagement is one of the most important drivers for improving healthcare delivery but approaches by European health technology assessment (HTA) bodies vary
We sat down with Sandoz’s head of digital Andre Heeg to discuss where digital pharma is heading and how companies can make sure they always keep the patient in mind during this transformation
Success requires addressing behaviour from the individual’s perspective, as well as a socio-cultural and environmental context, says Kantar’s Andy Stankus